---
title: "SUBRAMANIAN KALA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9ba46146-8cfa-511d-9e56-201cb795cbc4
json: https://whiteintel.dev/api/public/dossier/9ba46146-8cfa-511d-9e56-201cb795cbc4
identifier: sec:0001682026
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SUBRAMANIAN KALA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001682026`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9ba46146-8cfa-511d-9e56-201cb795cbc4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9ba46146-8cfa-511d-9e56-201cb795cbc4  

## Ownership & control

### Holdings / subsidiaries

- **CRISPR Therapeutics AG** (officer) — https://whiteintel.dev/entity/22e54c6c-e33f-551a-a743-d1632697d826

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SUBRAMANIAN KALA**. Human view: https://whiteintel.dev/entity/9ba46146-8cfa-511d-9e56-201cb795cbc4 · Structured JSON: https://whiteintel.dev/api/public/dossier/9ba46146-8cfa-511d-9e56-201cb795cbc4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._